1) 田村和朗 : 家族性腫瘍研究の展望と医療への貢献.家族性腫瘍─基礎と臨床の接点─(兵庫医科大学先端医学研究所家族性腫瘍部門・編),pp35─36,文部科学省特定領域研究「応用ゲノム」,2008
2) Chen S, Parmigiani G : Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25 : 1329─1333, 2007
3) がんの統計(2012年版): (がんの統計編集委員会編).公益財団法人がん研究振興財団,2012
4) Mavaddat N, Barrowdale D, Andrulis IL, et al : Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers : results from the Consortium of Investigators of Modifiers of BRCA 1/2(CIMBA). Cancer Epidemiol Biomarkers Prev 21 : 134─147, 2012
5) 日本産婦人科学会婦人科腫瘍委員会 : 婦人科腫瘍委員会2011年度患者年報.日産婦誌64 : 2340─2388, 2012
6) Bolton KL, Chenevix-Trench G, Goh C, et al : Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA 307 : 382─390, 2012
7) Tan DS, Rothermundt C, Thomas K, et al : “BRCAness” syndrome in ovarian cancer : a case-control study describling the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol 26 : 5530─5536, 2008
8) Iodice S, Barile M, Rotmensz N, et al : Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers : a meta-analysis. Eur J Cancer 46 : 2275─2284, 2010
9) Levine DA, Argenta PA, Yee CJ, et al : Fallopian tube and primary peritoneal carcinoma associated with BRCA mutations. J Clin Oncol 21 : 4222─4227, 2003
10) Piek JM, van Diest PJ, Zweemer RP, et al : Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195 : 451─456, 2001
11) Lee Y, Miron A, Drapkin R, et al : A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211 : 26─35, 2007
12) Cass I, Holschneider C, Datta N, et al : BRCA-mutation-assosiated fallopian tube carcinoma : a distinct clinical phenotype? Obstet Gynecol 106 : 1327─1334, 2005
13) Ramus SJ, Bobrow LG, Pharoah PD, et al : Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours. Genes Chromosomes Cancer 25 : 91─96, 1999
14) Natural Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/familial high-risk assessment : Breast and ovarian. Version 4, 2013
15) van der Velde, Mourits MJ, Arts HJ, et al : Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer 124 : 919─923, 2009
16) Rosenthal AN, Fraser L, Manchanda R, et al : Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. J Clin Oncol 31 : 49─57, 2013
17) 新井正美,岩瀬春子,岩瀬拓士,他 : BRCA1/2遺伝子変異保有者におけるリスク低下両側卵巣卵管切除術の実施(第1報).家族性腫瘍13 : 52─58, 2013
18) Rebbeck TR, Kauff ND, Domchek SM. : Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101 : 80─87, 2009
19) Domchek SM, Friebel TM, Singer CF, et al : Association of risk-reducing surgery in BRCA1 or BRCA2 mutaion carriers with cancer risk and mortality. JAMA 304 : 967─975, 2010
20) BRCA1あるいはBRCA2遺伝子変異をもつ女性に対するリスク軽減卵巣卵切除は有効か.日本乳癌学会(編),乳癌診療ガイドライン,pp85─87,東京,2013
21) Ligtenberg MJ, Kuiper RP, Chan TL, et al : Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3’exons of TACSTD1. Nat Genet 41 : 112─117, 2009
22) IIリンチ症候群・(1)概要,大腸癌研究会・編遺伝性大腸癌診療ガイドライン,pp32─34,金原出版,東京,2012
23) 婦人科腫瘍委員会報告,日産婦誌61 : 1540─1542, 2009
24) 古田玲子 : リンチ症候群に関連した子宮内膜の前癌病変および内膜がんの病理組織学的な特徴,家族性腫瘍13 : A29,2013
25) Gene Reviews Japanホームページ http://grj.umin.jp/
26) Bubien V, Bonnet F, Brouste V, et al : High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 50 : 255─263, 2013
27) Pilarski R, Burt R, Kohlman W, et al : Cowden syndrome and the PTEN hamartoma tumor syndrome : Systematic review and revised diagnostic criteria. J Natl Cancer Inst[Epub ahead of print], 2013
28) Young RH, Welch WR, Dickersin GR, et al : Ovarian sex cord tumor with annular tubules : review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 50 : 1384─1402, 1982